Literature DB >> 6923982

Recent experience with antimicrobial susceptibility of anaerobic bacteria: increasing resistance to penicillin.

R S Edson, J E Rosenblatt, D T Lee, E A McVey.   

Abstract

Results of antimicrobial susceptibility testing of anaerobes were reviewed for the last 5 years and compared with two previous surveys from this institution. Allowing for differences in methodology, there appears to be a striking increase in penicillin resistance by the "non-fragilis" Bacteroides. Penicillin concentrations of 50 microgram/ml were required to inhibit 70% of 43 strains tested. The clinical implications of this observation are not known, but isolated reports of therapeutic failure when penicillin was used against the non-fragilis Bacteroides have appeared. Penicillin resistance among Clostridium other than C. perfringens was also noted in the current study. Several strains of clindamycin-resistant Bacteroides fragilis have been observed during the last 2 years, and whether this represents a true increase in resistance will require close scrutiny of clindamycin susceptibility in the future. Future surveillance of antimicrobial susceptibility of anaerobic bacteria will be useful in the detection of any major changes in susceptibility profiles. This knowledge will potentially affect the choice of antimicrobial agent in patients with serious infections caused by anaerobes.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6923982

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  20 in total

1.  Difficult-to-treat infections.

Authors:  S de Marie
Journal:  Intensive Care Med       Date:  1990       Impact factor: 17.440

2.  In vitro susceptibilities of oral pigmented Bacteroides species to trospectomycin and other selected antimicrobial agents.

Authors:  C C Johnson; M Wendeler; M E Levison
Journal:  Antimicrob Agents Chemother       Date:  1990-08       Impact factor: 5.191

3.  Disk diffusion susceptibility testing of the Bacteroides fragilis group.

Authors:  R Horn; A M Bourgault; F Lamothe
Journal:  Antimicrob Agents Chemother       Date:  1987-10       Impact factor: 5.191

Review 4.  Pelvic inflammatory disease: current concepts and treatment guidelines.

Authors:  P A Dale; P A Rice; K C Edelin
Journal:  J Gen Intern Med       Date:  1986 Nov-Dec       Impact factor: 5.128

5.  Beta-lactamase production and susceptibilities to amoxicillin, amoxicillin-clavulanate, ticarcillin, ticarcillin-clavulanate, cefoxitin, imipenem, and metronidazole of 320 non-Bacteroides fragilis Bacteroides isolates and 129 fusobacteria from 28 U.S. centers.

Authors:  P C Appelbaum; S K Spangler; M R Jacobs
Journal:  Antimicrob Agents Chemother       Date:  1990-08       Impact factor: 5.191

6.  Rationale for selective use of anaerobic blood cultures.

Authors:  A J Morris; M L Wilson; S Mirrett; L B Reller
Journal:  J Clin Microbiol       Date:  1993-08       Impact factor: 5.948

7.  Modified broth-disk surveillance of clindamycin-resistant Bacteroides fragilis group.

Authors:  F A Zar
Journal:  Antimicrob Agents Chemother       Date:  1983-06       Impact factor: 5.191

8.  Susceptibilities of 428 gram-positive and -negative anaerobic bacteria to Bay y3118 compared with their susceptibilities to ciprofloxacin, clindamycin, metronidazole, piperacillin, piperacillin-tazobactam, and cefoxitin.

Authors:  G A Pankuch; M R Jacobs; P C Appelbaum
Journal:  Antimicrob Agents Chemother       Date:  1993-08       Impact factor: 5.191

9.  Anaerobic bacteremia: a retrospective four-year analysis in general medicine and cancer patients.

Authors:  R Kornowski; D Schwartz; M Averbuch; Y Levo; S Berger; M Giladi
Journal:  Infection       Date:  1993 Jul-Aug       Impact factor: 3.553

10.  Propionibacterium acnes osteomyelitis: case report and review of the literature.

Authors:  R C Noble; S B Overman
Journal:  J Clin Microbiol       Date:  1987-02       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.